Biopharma

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Date of authorisation: 13/09/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Viagra, sildenafil, Da...

Fierce Biotech Layoff Tracker 2025: Atara halves workforce; BMS axes 223 jobs

Fierce Biotech Layoff Tracker 2025: Atara halves workfo...

Mar 4, 2025 0

As always, if you know of layoffs occurring at a biotech, please reach out to th...

PepGen pauses UK arm of DMD trial that's already on hold in US

PepGen pauses UK arm of DMD trial that's already on hol...

Mar 4, 2025 0

While PepGen works to persuade the FDA to let it launch a phase 2 trial of its D...

Fierce Biotech Fundraising Tracker '25: Garuda grabs $50M series A; Callio launches with $187M

Fierce Biotech Fundraising Tracker '25: Garuda grabs $5...

Mar 4, 2025 0

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug

Glenmark issues another recall, this time for nearly 1....

Mar 4, 2025 0

Glenmark Pharma, an India-based drug manufacturer that has been the focal point ...

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, Date of authorisation: 20/04/2007, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, ...

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreoti...

Tech and service specialist Cytiva charts 85 layoffs at Massachusetts production site

Tech and service specialist Cytiva charts 85 layoffs at...

Mar 4, 2025 0

Cytiva will lay off 85 employees from its facility in Westborough, Massachusetts...

Questions about Pfizer’s GenAI ‘Health Answers’

Questions about Pfizer’s GenAI ‘Health Answers’

Mar 4, 2025 0

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to ho...

UPDATE: Biohaven's bipolar candidate fails to improve mania in pivotal trial

UPDATE: Biohaven's bipolar candidate fails to improve m...

Mar 4, 2025 0

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a ...

Wojcicki’s controversial bid to reclaim 23andMe

Wojcicki’s controversial bid to reclaim 23andMe

Mar 4, 2025 0

The biggest stories in biotech today, brought to you by The Readout.

STAT+: Pharmalittle: We’re reading about Pfizer navigating tariffs, Makary’s pledge to avoid conflicts, and more

STAT+: Pharmalittle: We’re reading about Pfizer navigat...

Mar 4, 2025 0

Pfizer CEO Albert Bourla said the drugmaker might move overseas manufacturing to...

EMEA-002727-PIP02-23

EMEA-002727-PIP02-23

Mar 4, 2025 0

EMEA-002727-PIP02-23

Human medicines European public assessment report (EPAR): Viramune, nevirapine, Date of authorisation: 04/02/1998, Revision: 45, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Viramune, nevirapine, ...

Human medicines European public assessment report (EPAR): Ryzodeg, insulin degludec,insulin aspart, Date of authorisation: 21/01/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Ryzodeg, insulin deglu...

EMEA-003484-PIP01-23

EMEA-003484-PIP01-23

Mar 4, 2025 0

EMEA-003484-PIP01-23

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolo...

Atara, reeling from FDA hold on Ebvallo, lays off half of workforce

Atara, reeling from FDA hold on Ebvallo, lays off half ...

Mar 4, 2025 0

Atara Biotherapeutics is halving its headcount as it navigates the fallout from ...

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Lutathera, lutetium (1...

VC firm Sofinnova brings in €1.2B over a year to fund up to 60 life sciences companies

VC firm Sofinnova brings in €1.2B over a year to fund u...

Mar 4, 2025 0

Up to 60 new life sciences companies are set to benefit from 1.2 billion euros (...

1 in 6 young people will have obesity by 2050, analysis predicts

1 in 6 young people will have obesity by 2050, analysis...

Mar 4, 2025 0

And other health news stories to stay on top of.

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Baiama, aflibercept, D...

Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda

Blocking PD-1 and VEGF: The bispecific cancer drugs tha...

Mar 4, 2025 0

Striking study results last year indicated a new type of medicine may improve on...

Biohaven's biopolar candidate fails to improve mania in pivotal trial

Biohaven's biopolar candidate fails to improve mania in...

Mar 4, 2025 0

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.